Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Frequency of Cancer Associated With Children and Adolescents Publisher



Toloughamari Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nosocomial Infection Research Center, Deputy of Research and Technology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: New Emirates Medical Journal Published:2024


Abstract

Background: More than 175,000 new cases of cancer in children are diagnosed every year worldwide. This study aimed to investigate the recorded cancer frequency in children and adolescents in Isfahan Province, Iran. As one of the main reasons for death among children and adolescents is reported as cancer with different prevalence worldwide, therefore, reporting the occurrence of cancers in this population is crucial. Methods: Information from the years between 2013 to 2015 related to the Surveillance, Epidemiology, and End Results; (SEER) was collected from the Isfahan Cancer Registry. The cancer sites studied were defined according to the International Classification of Diseases and recorded by related topography codes. Results: Among all 30,465 registered cancers, there were 582 cases (2%) of cancer, including 57% of children and 43% of adolescents. The mean ± SD age of patients was 11.5 ± 5.9 years (Min; 1, Max 19). The top four ranked cancers were (n=264; 45%) comprised of; 1) hematopoietic and reticuloendothelial system (n= 122), 2) secondary and unspecified malignant neoplasm of lymph nodes (n=56), 3) malignant neoplasm of the brain (n=43) 4), thyroid gland (n=43). Death-reported data was associated with 32% of the total population studied. The neoplasm was reported in 174 cases, which was associated with 95% death. Conclusion: This frequency source of children and adolescents cancers could be used for health strategy. The observed variations in the frequency of different cancers require continuous monitoring and investigation. Therefore, plan of health-system should focus based on greater efforts toward advanced evidence-based drug therapy in Isfahan, Iran. © 2024 The Author(s). Published by Bentham Science Publisher.
Other Related Docs
9. Investigation of Bladder Cancer Incidence in Isfahan, Iran, Tehran University Medical Journal (2019)
10. The Most Common Cancers in Iranian Women, Iranian Journal of Public Health (2009)
11. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)
13. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
15. Prevalence of Stomach Cancer in Isfahan Province, Iran, The Gulf journal of oncology (2018)
16. The Epidemiology of Skin Cancer and Its Trend in Iran, International Journal of Preventive Medicine (2015)
22. Trends in Colorectal Cancer Incidence in Iran, Journal of Mazandaran University of Medical Sciences (2015)
23. The Economic Cost of Cancer Treatment in Iran, Journal of Education and Health Promotion (2023)
24. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
25. Locoregional Recurrence of Breast Cancer and Its Predictive Factors, Journal of Isfahan Medical School (2012)
28. Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Cancer Prevention (2019)
30. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
36. Challenges of Children With Cancer and Their Mothers: A Qualitative Research, Iranian Journal of Nursing and Midwifery Research (2014)
41. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
42. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
44. Incidence of Breast and Cervical Intraepithelial Lesions: Results of a Screening Program for Women, Journal of Obstetrics, Gynecology and Cancer Research (2022)